| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 55 |
| 1 | METHOTREXATE | 49 |
| 2 | TACROLIMUS | 35 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 32 |
| 4 | TACROLIMUS OINTMENT 0.1% | 32 |
| 5 | MYCOPHENOLATE MOFETIL | 29 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 29 |
| 7 | AZATHIOPRINE | 28 |
| 8 | CYCLOPHOSPHAMIDE | 27 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACITRETIN | 21 | 0.0043 |
| 1 | DATOPOTAMAB DERUXTECAN | 2 | 0.0023 |
| 2 | MARAVIROC | 2 | 0.0009 |
| 3 | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | 2 | 0.0009 |
| 4 | AXICABTAGENE CILOLEUCEL | 8 | 0.0008 |
| 5 | HUMAN IMMUNOGLOBULIN G | 16 | 0.0008 |
| 6 | PENTOXIFYLLINE | 3 | 0.0007 |
| 7 | LECANEMAB | 2 | 0.0005 |
| 8 | ITRACONAZOLE | 6 | 0.0005 |
| 9 | RALTEGRAVIR | 2 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 67 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 49 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 32 |
| 3 | Purine Antimetabolite [EPC] | 30 |
| 4 | Alkylating Drug [EPC] | 28 |
| 5 | Aminosalicylate [EPC] | 28 |
| 6 | Interleukin-17A Antagonist [EPC] | 28 |
| 7 | Calcineurin Inhibitor Immunosuppressant [EPC] | 26 |
| 8 | Janus Kinase Inhibitor [EPC] | 25 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 23 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 3 | CD19-directed Chimeric Antigen Receptor [EPC] | 8 | 0.0008 |
| 4 | Human Immunoglobulin G [EPC] | 16 | 0.0008 |
| 5 | Interleukin-17A Antagonist [EPC] | 28 | 0.0008 |
| 6 | Blood Viscosity Reducer [EPC] | 3 | 0.0007 |
| 7 | Amyloid Beta-directed Antibody [EPC] | 2 | 0.0005 |
| 8 | Calcitonin [EPC] | 1 | 0.0003 |
| 9 | Purine Antimetabolite [EPC] | 30 | 0.0003 |